Nutritional Problems After Lung and Heart Transplantation

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00826254

Enrollment

Registered

2009-01-22

Start date

2003-08-31

Completion date

2011-12-31

Last updated

2011-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Density, Overweight

Keywords

vitamin K, Bone Mineral Density, undercarboxylated osteocalcin

Brief summary

Part 1) Bone health after transplantation - possible influence of vitamin K Part 2) Fat metabolism and endocrine parameters - possible predictors for developement of overweight after transplantation

Interventions

DRUGVitamin K

180 micrograms vitamin K daily

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

20 Years to 70 Years

Healthy volunteers

Inclusion criteria

* accepted for transplantation

Exclusion criteria

* not accepted for transplantation

Design outcomes

Primary

Measure	Time frame
plasma vitamin K	1 year

Secondary

Measure	Time frame
Bone mineral density	1 year

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026